DCBO Docebo Inc. IFRS
Services-Prepackaged Software · Nasdaq · SEC CIK 1829959 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2025Q1*2025-03-31 | 2024Q4*2024-12-31 | 2024Q3*2024-09-30 | 2024Q1*2024-03-31 | 2023Q4*2023-12-31 | 2023Q3*2023-09-30 | 2023Q2*2023-06-30 | 2023Q1*2023-03-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $57.30M | $57.04M | $55.43M | $51.40M | $49.28M | $46.51M | $43.59M | $41.46M |
| Cost of revenue | $11.39M | $10.65M | $10.46M | $9.93M | $9.26M | $8.78M | $8.41M | $8.05M |
| Gross profit | $45.90M | $46.39M | $44.97M | $41.48M | $40.02M | $37.73M | $35.18M | $33.41M |
| R&D expense | $13.40M | $11.58M | $11.15M | $10.41M | $9.02M | $10.27M | $8.81M | $7.38M |
| SG&A expense | $8.72M | $7.87M | $8.38M | $8.15M | $8.57M | $8.32M | $9.35M | $7.56M |
| Operating income | $1.71M | $7.83M | $4.72M | $4.23M | $1.08M | $3.11M | -$7.52M | -$376,000 |
| Pretax income | $2.36M | $8.39M | $5.34M | $4.77M | $3.31M | $5.04M | -$5.12M | $1.61M |
| Income tax | $883,000 | -$3.52M | $382,000 | -$396,000 | $88,000 | $997,000 | $558,000 | $363,000 |
| Net income | $1.47M | $11.91M | $4.96M | $5.17M | $3.22M | $4.05M | -$5.67M | $1.25M |
| EBITDA | $2.51M | $8.69M | $5.59M | $5.04M | $1.63M | $4.17M | -$6.70M | $331,000 |
| EPS (basic) | 0.05 | — | 0.16 | 0.17 | — | 0.12 | -0.17 | 0.04 |
| EPS (diluted) | 0.05 | — | 0.16 | 0.17 | — | 0.12 | -0.17 | 0.04 |
| Weighted avg. shares (diluted) | 30.93M | — | 30.94M | 31.04M | — | 33.51M | 33.15M | 34.16M |
| Balance sheet | ||||||||
| Cash & equivalents | $91.87M | $92.54M | $82.03M | $80.65M | $71.95M | $170.65M | $203.92M | $215.83M |
| Receivables | $50.99M | $45.57M | $40.28M | $45.05M | $41.77M | $40.89M | $39.41M | $45.48M |
| Current assets | $161.77M | $154.24M | $140.81M | $140.91M | $127.15M | $224.66M | $258.85M | $274.97M |
| PP&E, netmay include right-of-use assets (IFRS) | $2.07M | $2.00M | $2.16M | $1.96M | $2.11M | $2.12M | $2.34M | $2.47M |
| Goodwill | $14.05M | $13.85M | $14.32M | $14.04M | $14.25M | $9.86M | $10.04M | $6.06M |
| Intangibles | $1.52M | $1.67M | $1.88M | $2.21M | $2.40M | $6.41M | $6.81M | $1.08M |
| Total assets | $197.67M | $190.71M | $174.14M | $173.07M | $158.38M | $254.18M | $288.96M | $295.15M |
| Current liabilities | $140.57M | $128.60M | $124.85M | $108.39M | $100.65M | $110.83M | $137.60M | $92.88M |
| Total liabilities | $145.24M | $132.95M | $129.08M | $113.43M | $107.65M | $118.47M | $144.43M | $99.91M |
| Shareholders' equity | $52.43M | $57.76M | $45.06M | $59.64M | $50.72M | $135.70M | $144.54M | $195.25M |
| Cash flow statement | ||||||||
| Operating cash flow | $7.95M | $9.73M | — | $8.43M | $6.48M | $6.21M | $5.45M | -$2.18M |
| Capital expenditure | $298,000 | $287,000 | — | $203,000 | $249,000 | $120,000 | $159,000 | $107,000 |
| Free cash flow | $7.65M | $9.44M | — | $8.22M | $6.23M | $6.09M | $5.29M | -$2.29M |
| Investing cash flow | -$298,000 | -$287,000 | — | -$203,000 | -$249,000 | -$120,000 | -$9.05M | -$107,000 |
| Financing cash flow | -$8.80M | $2.01M | — | $521,000 | -$105.38M | -$39.02M | -$8.30M | $1.70M |
| Depreciation & amortization | $798,000 | $865,000 | $877,000 | $818,000 | $554,000 | $1.06M | $824,000 | $707,000 |
| Stock-based compensation | $789,000 | $1.66M | $1.81M | $1.93M | $1.61M | $1.84M | $1.33M | $1.27M |
Free plan shows the latest 8 periods; Pro shows all 16 🔒
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.